Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act

Bill 118 hr 2365, also known as the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act, is a piece of legislation introduced in the US Congress with the goal of creating a national plan to combat Parkinson's disease. The bill is named after Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton, who are both advocates for Parkinson's research and treatment.

The main objective of the bill is to establish a comprehensive strategy to address the challenges faced by individuals living with Parkinson's disease. This includes improving access to care, increasing funding for research, and promoting education and awareness about the disease. The bill also aims to enhance coordination among federal agencies, healthcare providers, and advocacy organizations to ensure a unified approach to tackling Parkinson's.

Additionally, the bill calls for the creation of a Parkinson's Disease Council, which will be responsible for developing and implementing the national plan. The council will consist of experts in the field of Parkinson's research, healthcare providers, and individuals living with the disease. Overall, the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act seeks to improve the quality of life for individuals affected by Parkinson's disease and ultimately work towards finding a cure. It represents a bipartisan effort to address a pressing public health issue and highlights the importance of collaboration and innovation in the fight against Parkinson's.